Cargando…

Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy

Over the past decade, messenger RNA (mRNA) has emerged as potent and flexible platform for the development of novel effective cancer immunotherapies. Advances in non-viral gene delivery technologies, especially the tremendous progress in lipid nanoparticles' manufacturing, have made possible th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guevara, Maria L., Persano, Francesca, Persano, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645050/ https://www.ncbi.nlm.nih.gov/pubmed/33195094 http://dx.doi.org/10.3389/fchem.2020.589959

Ejemplares similares

Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration
por: Guevara, Maria L., et al.
Publicado: (2019)

Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
por: Han, Jieun, et al.
Publicado: (2023)

Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy
por: Karmacharya, Prajeena, et al.
Publicado: (2022)

Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
por: Wang, Hong-Li, et al.
Publicado: (2022)

Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy
por: Wilhelmy, Christoph, et al.
Publicado: (2023)

mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
por: Sasaki, Kosuke, et al.
Publicado: (2022)

Recent Advances in Lipid Nanoparticles for Delivery of mRNA
por: Yang, Lei, et al.
Publicado: (2022)

Nano-Clays for Cancer Therapy: State-of-the Art and Future Perspectives
por: Persano, Francesca, et al.
Publicado: (2022)

Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects
por: Huang, Tao, et al.
Publicado: (2022)

Lipid nanoparticles for mRNA delivery
por: Hou, Xucheng, et al.
Publicado: (2021)

RGD peptide-based lipids for targeted mRNA delivery and gene editing applications
por: Qin, Jingya, et al.
Publicado: (2022)

Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
por: Swetha, K., et al.
Publicado: (2023)

Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery
por: Xu, Xiao, et al.
Publicado: (2023)

Lipid-mRNA nanoparticles landscape for cancer therapy
por: Li, Yin, et al.
Publicado: (2022)

From lipids to lipid nanoparticles to mRNA vaccines
por: Horejs, Christine
Publicado: (2021)

mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy
por: Li, Fengqiao, et al.
Publicado: (2023)

mRNA lipid nanoparticle phase transition
por: Trollmann, Marius F.W., et al.
Publicado: (2022)

mRNA vaccines for cancer immunotherapy
por: Vishweshwaraiah, Yashavantha L., et al.
Publicado: (2022)

Low-defectiveness exfoliation of MoS(2) nanoparticles and their embedment in hybrid light-emitting polymer nanofibers
por: Portone, Alberto, et al.
Publicado: (2018)

Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles
por: Delehedde, Christophe, et al.
Publicado: (2021)

Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles
por: Lewis, Mae M., et al.
Publicado: (2023)

Label-Free Isothermal Amplification Assay for Specific and Highly Sensitive Colorimetric miRNA Detection
por: Persano, Stefano, et al.
Publicado: (2016)

Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
por: Deal, Cailin E., et al.
Publicado: (2021)

Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas
por: Persano, Francesca, et al.
Publicado: (2022)

mRNA therapeutics in cancer immunotherapy
por: Beck, Jan D., et al.
Publicado: (2021)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

mRNA delivery in cancer immunotherapy
por: Zhong, Yichen, et al.
Publicado: (2023)

Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery
por: Han, Geonhee, et al.
Publicado: (2023)

Delivery of mRNA to platelets using lipid nanoparticles
por: Novakowski, S., et al.
Publicado: (2019)

Ionizable lipid nanoparticles for in utero mRNA delivery
por: Riley, Rachel S., et al.
Publicado: (2021)

Payload distribution and capacity of mRNA lipid nanoparticles
por: Li, Sixuan, et al.
Publicado: (2022)

Highly sticky surfaces made by electrospun polymer nanofibers
por: Varagnolo, S., et al.
Publicado: (2017)

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
por: Semple, Sean C., et al.
Publicado: (2022)

Immunity of the Saccharomyces cerevisiae SSY5 mRNA to nonsense-mediated mRNA decay
por: Obenoskey, Jesseeca, et al.
Publicado: (2014)

Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
por: Mukai, Hidefumi, et al.
Publicado: (2022)

Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?
por: Puccetti, Matteo, et al.
Publicado: (2023)

Elucidation of lipid nanoparticle surface structure in mRNA vaccines
por: Wang, Mingzhang Maple, et al.
Publicado: (2023)

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
por: Hassett, Kimberly J., et al.
Publicado: (2019)

Future considerations for the mRNA-lipid nanoparticle vaccine platform
por: Igyártó, Botond Z, et al.
Publicado: (2021)

Principles for designing an optimal mRNA lipid nanoparticle vaccine
por: Kon, Edo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gpgtb0cijkve7r9jnk80vt807k